Performance of Tension Free Vaginal Mesh (Prolift) Versus Conventional Vaginal Prolapse Surgery in Recurrent Prolapse.

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2008 by Radboud University.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Radboud University
ClinicalTrials.gov Identifier:
NCT00372190
First received: September 5, 2006
Last updated: June 6, 2008
Last verified: June 2008

September 5, 2006
June 6, 2008
August 2006
October 2008   (final data collection date for primary outcome measure)
Prolapse by POPQ, at entry, after 6 months, after 12 months [ Time Frame: at entry, 6 months and 12 months ] [ Designated as safety issue: No ]
  • Prolapse by POPQ, at entry, after 6 months, after 12 months
  • Prolapse complaints by standardised questionnaire, at entry, after 6 months, after 12 months
  • Quality of life by standardised questionnaire, at entry, after 6 months, after 12 months
Complete list of historical versions of study NCT00372190 on ClinicalTrials.gov Archive Site
  • Complications during the procedure, after 6 weeks, after 6 months, after 12 months [ Time Frame: during procedure, after 6 weeks, 6 months and 12 months ] [ Designated as safety issue: Yes ]
  • Quality of life by standardised questionnaire, at entry, after 6 months, after 12 months [ Time Frame: at entry, after 6 months and 12 months ] [ Designated as safety issue: No ]
  • prolapse complaints by standardised questionnaires [ Time Frame: at entry, after 6 weeks, 6 months and 12 months ] [ Designated as safety issue: No ]
Complications during the procedure, after 6 weeks, after 6 months, after 12 months
Not Provided
Not Provided
 
Performance of Tension Free Vaginal Mesh (Prolift) Versus Conventional Vaginal Prolapse Surgery in Recurrent Prolapse.
A Prospective and Comparative Study of the Performance of Tension Free Vaginal Mesh (Prolift) Versus Conventional Vaginal Prolapse Surgery in Recurrent Prolapse

Pelvic organ prolapse is a common problem. A lot of women have surgery for prolapse. The recurrence rate op pelvic organ prolapse after surgical treatment is high. Placement of a mesh aims at reducing the recurrence rate, but mesh implants can cause complications.

This study is designed to determine the effectiveness of one type of mesh (tensionfree vaginal mesh; Prolift), compared with the standard prolapse surgery. A secondary objective is to track the complications of both procedures.

Patients with recurrent prolapse after surgery can participate in this study. A total of 194 women will be included. At random 97 patients undergo a standard prolapse operation and 97 patients undergo an operation with the mesh. Evaluation will take place during surgery, at the postoperative visit after six weeks, and after six months and twelve months. Quality of life, degree of vaginal prolapse, subjective effectiveness, safety and incidence of complications will be evaluated.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Pelvic Organ Prolapse
  • Procedure: Tensionfree vaginal mesh (Prolift)
    surgery with Prolift mesh
  • Procedure: classic vaginal prolapse surgery (fascia plication)
    classic surgery, fascia plication
  • Experimental: 1
    Tensionfree vaginal mesh (Prolift)
    Intervention: Procedure: Tensionfree vaginal mesh (Prolift)
  • Active Comparator: 2
    classic vaginal prolapse surgery (fascia plication)
    Intervention: Procedure: classic vaginal prolapse surgery (fascia plication)

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
194
Not Provided
October 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • recurrent anterior and/or posterior prolapse POP-Q stage 2 or more
  • patient has agreed to undergo implantation of TVM (prolift) or fascial plication
  • patient is willing to return for follow-up evaluation at 6 weeks, 6 months and 12 months
  • patient is willing to complete quality of life questionnaires at 6 and 12 months

Exclusion Criteria:

  • patient is or wants to become pregnant
  • patient has had previous synthetic mesh procedure (a previous mid-urethral sling procedure is NOT an exclusion criterion)
  • patient has current urinary tract or vaginal infections
  • patient has a blood coagulation disorder
  • patient has a compromised immune system or any other condition that would compromise healing
  • patient has renal insufficiency and/or upper urinary tract obstruction
  • patient is unwilling or unable to return for evaluation
  • patient has had previous irradiation
  • patient has any malignancy
  • patient has large ovarian cysts of large myoma
Female
Not Provided
No
Contact: Mariella ij Withagen, Drs. 0031243614792 m.withagen@obgyn.umcn.nl
Contact: Mark e Vierhout, Prof. Dr. 0031243614728 m.vierhout@obgyn.umcn.nl
Netherlands
 
NCT00372190
P0609
Not Provided
M.I.J. Withagen, Radboud University, department of obstetrics and gynaecology
Radboud University
Not Provided
Principal Investigator: Mariella ij Withagen, Drs. UMC St Radboud
Radboud University
June 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP